ACIM
GILD icon

Azimuth Capital Investment Management’s Gilead Sciences GILD Stock Holding History

Azimuth Capital Investment Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.4M Buy
96,471
+1,875
+2% +$263K 0.51% 66
2025
Q4 		$11.6M Buy
94,596
+742
+0.8% +$90.2K 0.42% 78
2025
Q3 		$10.4M Sell
93,854
-576
-0.6% -$65.5K 0.37% 87
2025
Q2 		$10.5M Sell
94,430
-1,510
-2% -$161K 0.39% 90
2025
Q1 		$10.8M Sell
95,940
-15,675
-14% -$1.62M 0.43% 73
2024
Q4 		$10.3M Buy
111,615
+1,170
+1% +$105K 0.4% 81
2024
Q3 		$9.26M Buy
110,445
+565
+0.5% +$43.1K 0.36% 95
2024
Q2 		$7.54M Sell
109,880
-290
-0.3% -$19.4K 0.31% 107
2024
Q1 		$8.07M Sell
110,170
-18,470
-14% -$1.42M 0.33% 103
2023
Q4 		$10.4M Buy
128,640
+167
+0.1% +$13K 0.47% 73
2023
Q3 		$9.63M Buy
128,473
+268
+0.2% +$20.6K 0.47% 68
2023
Q2 		$9.88M Sell
128,205
-1,750
-1% -$140K 0.47% 68
2023
Q1 		$10.8M Sell
129,955
-155
-0.1% -$12.8K 0.53% 63
2022
Q4 		$11.2M Sell
130,110
-3,175
-2% -$251K 0.57% 55
2022
Q3 		$8.22M Sell
133,285
-655
-0.5% -$41.3K 0.45% 71
2022
Q2 		$8.28M Buy
+133,940
New +$8.29M 0.42% 80

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Azimuth Capital Investment Management's GILD Position: Q1 2026 in Review

Azimuth Capital Investment Management increased its Gilead Sciences (GILD) stake by 2% in Q1 2026, buying an estimated $263K and bringing the position to 96,471 shares worth $13.4M. The position accounts for 0.51% of the portfolio, ranked #66.

Azimuth Capital Investment Management first reported a position in GILD in Q2 2022 and has held it in 16 quarters since. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Azimuth Capital Investment Management held 96,471 shares of Gilead Sciences worth $13.4M as of Q1 2026.
  • Azimuth Capital Investment Management bought 1,875 Gilead Sciences shares in Q1 2026, an estimated $263K.
  • Gilead Sciences made up 0.51% of Azimuth Capital Investment Management's portfolio in Q1 2026, its #66 holding.
  • Azimuth Capital Investment Management first reported a position in Gilead Sciences in Q2 2022 and has held it in 16 quarters since.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Azimuth Capital Investment Management's 13F filing for Q1 2026, filed 12 May 2026.